Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Alpha1-antitrypsin deficiency.

Stoller JK, Aboussouan LS.

Lancet. 2005 Jun 25-Jul 1;365(9478):2225-36. Review.

PMID:
15978931
2.

A review of α1-antitrypsin deficiency.

Stoller JK, Aboussouan LS.

Am J Respir Crit Care Med. 2012 Feb 1;185(3):246-59. doi: 10.1164/rccm.201108-1428CI. Epub 2011 Sep 29. Review.

PMID:
21960536
3.

Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?

Modrykamien A, Stoller JK.

Expert Opin Pharmacother. 2009 Nov;10(16):2653-61. doi: 10.1517/14656560903300111. Review.

PMID:
19827990
4.

[Alpha-1 antitrypsin deficiency: diagnosis and treatment].

Camelier AA, Winter DH, Jardim JR, Barboza CE, Cukier A, Miravitlles M.

J Bras Pneumol. 2008 Jul;34(7):514-27. Review. Portuguese.

5.

Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?

Abboud RT, Ford GT, Chapman KR.

Treat Respir Med. 2005;4(1):1-8. Review.

PMID:
15725045
6.

Augmentation therapy in alpha-1 antitrypsin deficiency.

Heresi GA, Stoller JK.

Expert Opin Biol Ther. 2008 Apr;8(4):515-26. doi: 10.1517/14712598.8.4.515 . Review.

PMID:
18352854
7.

Intrapleural administration of an AAVrh.10 vector coding for human α1-antitrypsin for the treatment of α1-antitrypsin deficiency.

Chiuchiolo MJ, Kaminsky SM, Sondhi D, Hackett NR, Rosenberg JB, Frenk EZ, Hwang Y, Van de Graaf BG, Hutt JA, Wang G, Benson J, Crystal RG.

Hum Gene Ther Clin Dev. 2013 Dec;24(4):161-73. doi: 10.1089/humc.2013.168.

PMID:
24191907
8.

α1-Antitrypsin Deficiency.

Hatipoğlu U, Stoller JK.

Clin Chest Med. 2016 Sep;37(3):487-504. doi: 10.1016/j.ccm.2016.04.011. Epub 2016 Jun 25. Review.

PMID:
27514595
9.

Lung disease due to alpha 1-antitrypsin deficiency.

Wiedemann HP, Stoller JK.

Curr Opin Pulm Med. 1996 Mar;2(2):155-60. Review.

PMID:
9363132
10.

Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Dickens JA, Lomas DA.

Drug Des Devel Ther. 2011;5:391-405. doi: 10.2147/DDDT.S14018. Epub 2011 Aug 17. Review.

11.

Alpha one antitrypsin deficiency: from gene to treatment.

Wood AM, Stockley RA.

Respiration. 2007;74(5):481-92. Review.

PMID:
17671403
12.

Genetic variants of alpha1-antitrypsin.

Salahuddin P.

Curr Protein Pept Sci. 2010 Mar;11(2):101-17. Review.

PMID:
19751191
13.

Molecular pathogenesis of alpha-1-antitrypsin deficiency.

Duvoix A, Roussel BD, Lomas DA.

Rev Mal Respir. 2014 Dec;31(10):992-1002. doi: 10.1016/j.rmr.2014.03.015. Epub 2014 Nov 20. Review.

PMID:
25442121
14.

Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.

Ogushi F, Fells GA, Hubbard RC, Straus SD, Crystal RG.

J Clin Invest. 1987 Nov;80(5):1366-74.

15.

The selective advantage of alpha1-antitrypsin deficiency.

Lomas DA.

Am J Respir Crit Care Med. 2006 May 15;173(10):1072-7. Epub 2006 Jan 26. Review.

PMID:
16439713
16.

α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.

Sclar DA, Evans MA, Robison LM, Skaer TL.

Clin Drug Investig. 2012 May 1;32(5):353-60. doi: 10.2165/11631920-000000000-00000.

PMID:
22480280
18.

Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.

Elliott PR, Bilton D, Lomas DA.

Am J Respir Cell Mol Biol. 1998 May;18(5):670-4.

PMID:
9569237
19.

Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.

Gadek JE, Fulmer JD, Gelfand JA, Frank MM, Petty TL, Crystal RG.

J Clin Invest. 1980 Jul;66(1):82-87.

Supplemental Content

Support Center